+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Chronic Obstructive Pulmonary Disease Market and Competitive Landscape - 2020

  • ID: 5023573
  • Report
  • April 2020
  • Region: Global
  • Fore Pharma
1 of 2
The research report Global Chronic Obstructive Pulmonary Disease Market and Competitive Landscape - 2020, provides comprehensive insights into the Chronic Obstructive Pulmonary Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Chronic Obstructive Pulmonary Disease market size and drug sales. It also provides insights into Chronic Obstructive Pulmonary Disease epidemiology and late stage pipeline.

This research covers the following: Chronic Obstructive Pulmonary Disease treatment options, Chronic Obstructive Pulmonary Disease late stage clinical trials pipeline, Chronic Obstructive Pulmonary Disease prevalence by countries, Chronic Obstructive Pulmonary Disease market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).

Research Scope:
  • Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
  • Chronic Obstructive Pulmonary Disease pipeline: Find out drugs in clinical trials for the treatment of Chronic Obstructive Pulmonary Disease by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Chronic Obstructive Pulmonary Disease epidemiology: Find out the number of patients diagnosed (prevalence) with Chronic Obstructive Pulmonary Disease by countries
  • Chronic Obstructive Pulmonary Disease drugs: Identify key drugs marketed and prescribed for Chronic Obstructive Pulmonary Disease in the US, including trade name, molecule name, and company
  • Chronic Obstructive Pulmonary Disease drugs sales: Find out the sales value for Chronic Obstructive Pulmonary Disease drugs by countries
  • Chronic Obstructive Pulmonary Disease market valuations: Find out the market size for Chronic Obstructive Pulmonary Disease drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Chronic Obstructive Pulmonary Disease drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Chronic Obstructive Pulmonary Disease drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Chronic Obstructive Pulmonary Disease market
  • Develop in-depth knowledge of competition and markets
  • Analyze Chronic Obstructive Pulmonary Disease drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Chronic Obstructive Pulmonary Disease market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 2
1. Chronic Obstructive Pulmonary Disease Treatment Options

2. Chronic Obstructive Pulmonary Disease Pipeline Insights
2.1. Chronic Obstructive Pulmonary Disease Phase 3 Clinical Trials
2.2. Chronic Obstructive Pulmonary Disease Phase 2 Clinical Trials
2.3. Chronic Obstructive Pulmonary Disease Phase 1 Clinical Trials

3. Chronic Obstructive Pulmonary Disease Epidemiology Analysis by Countries

4. US Chronic Obstructive Pulmonary Disease Market Insights
4.1. Marketed Drugs for Chronic Obstructive Pulmonary Disease in US
4.2. US Chronic Obstructive Pulmonary Disease Market Size & Forecast
4.3. US Chronic Obstructive Pulmonary Disease Drugs Sales & Forecast
4.4. US Chronic Obstructive Pulmonary Disease Market Share Analysis

5. Germany Chronic Obstructive Pulmonary Disease Market Insights
5.1. Marketed Drugs for Chronic Obstructive Pulmonary Disease in Germany
5.2. Germany Chronic Obstructive Pulmonary Disease Market Size & Forecast
5.3. Germany Chronic Obstructive Pulmonary Disease Drugs Sales Forecast
5.4. Germany Chronic Obstructive Pulmonary Disease Market Share Analysis

6. France Chronic Obstructive Pulmonary Disease Market Insights
6.1. Marketed Drugs for Chronic Obstructive Pulmonary Disease in France
6.2. France Chronic Obstructive Pulmonary Disease Market Size & Forecast
6.3. France Chronic Obstructive Pulmonary Disease Product Sales Forecast
6.4. France Chronic Obstructive Pulmonary Disease Market Share Analysis

7. Italy Chronic Obstructive Pulmonary Disease Market Insights
7.1. Marketed Drugs for Chronic Obstructive Pulmonary Disease in Italy
7.2. Italy Chronic Obstructive Pulmonary Disease Market Size & Forecast
7.3. Italy Chronic Obstructive Pulmonary Disease Product Sales Forecast
7.4. Italy Chronic Obstructive Pulmonary Disease Market Share Analysis

8. Spain Chronic Obstructive Pulmonary Disease Market Insights
8.1. Marketed Drugs for Chronic Obstructive Pulmonary Disease in Spain
8.2. Spain Chronic Obstructive Pulmonary Disease Market Size & Forecast
8.3. Spain Chronic Obstructive Pulmonary Disease Product Sales Forecast
8.4. Spain Chronic Obstructive Pulmonary Disease Market Share Analysis

9. UK Chronic Obstructive Pulmonary Disease Market Insights
9.1. Marketed Drugs for Chronic Obstructive Pulmonary Disease in UK
9.2. UK Chronic Obstructive Pulmonary Disease Market Size & Forecast
9.3. UK Chronic Obstructive Pulmonary Disease Product Sales Forecast
9.4. UK Chronic Obstructive Pulmonary Disease Market Share Analysis

10. Europe Chronic Obstructive Pulmonary Disease Market Insights
10.1. Europe Chronic Obstructive Pulmonary Disease Market Size & Forecast
10.2. Europe Chronic Obstructive Pulmonary Disease Product Sales Forecast
10.3. Europe Chronic Obstructive Pulmonary Disease Market Share Analysis

11. Japan Chronic Obstructive Pulmonary Disease Market Insights
11.1. Marketed Drugs for Chronic Obstructive Pulmonary Disease in Japan
11.2. Japan Chronic Obstructive Pulmonary Disease Market Size & Forecast
11.3. Japan Chronic Obstructive Pulmonary Disease Product Sales Forecast
11.4. Japan Chronic Obstructive Pulmonary Disease Market Share Analysis

12. Global Chronic Obstructive Pulmonary Disease Market Insights
12.1. Global Chronic Obstructive Pulmonary Disease Market Size & Forecast
12.2. Global Chronic Obstructive Pulmonary Disease Product Sales Forecast
12.3. Global Chronic Obstructive Pulmonary Disease Market Share Analysis

13. Research Methodology

List of Tables
Table 1: Chronic Obstructive Pulmonary Disease Phase 3 Clinical Trials, Global, 2020
Table 2: Chronic Obstructive Pulmonary Disease Phase 2 Clinical Trials, Global, 2020
Table 3: Chronic Obstructive Pulmonary Disease Phase 1 Clinical Trials, Global, 2020
Table 4: Chronic Obstructive Pulmonary Disease Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Chronic Obstructive Pulmonary Disease in US, 2019
Table 6: US Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 - 2024
Table 7: US Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Table 8: US Chronic Obstructive Pulmonary Disease Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Chronic Obstructive Pulmonary Disease in Germany, 2019
Table 10: Germany Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 - 2024
Table 11: Germany Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Table 12: Germany Chronic Obstructive Pulmonary Disease Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Chronic Obstructive Pulmonary Disease in France, 2019
Table 14: France Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 - 2024
Table 15: France Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Table 16: France Chronic Obstructive Pulmonary Disease Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Chronic Obstructive Pulmonary Disease in Italy, 2019
Table 18: Italy Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 - 2024
Table 19: Italy Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Table 20: Italy Chronic Obstructive Pulmonary Disease Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Chronic Obstructive Pulmonary Disease in Spain, 2019
Table 22: Spain Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 - 2024
Table 23: Spain Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Table 24: Spain Chronic Obstructive Pulmonary Disease Market Events and Trends, 2016 - 2024
Table 25: Marketed Drugs for Chronic Obstructive Pulmonary Disease in UK, 2019
Table 26: UK Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 - 2024
Table 27: UK Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Table 28: UK Chronic Obstructive Pulmonary Disease Market Events and Trends, 2016 - 2024
Table 29: Europe Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 - 2024
Table 30: Europe Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Table 31: Marketed Drugs for Chronic Obstructive Pulmonary Disease in Japan, 2019
Table 32: Japan Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 - 2024
Table 33: Japan Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Table 34: Japan Chronic Obstructive Pulmonary Disease Market Events and Trends, 2016 - 2024
Table 35: Global Chronic Obstructive Pulmonary Disease Market Size & Forecast ($mn), 2016 - 2024
Table 36: Global Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Chronic Obstructive Pulmonary Disease Pipeline by Phase (%), Global, 2020
Figure 2: Chronic Obstructive Pulmonary Disease Prevalence by Countries, 2016 - 2024
Figure 3: US Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 - 2024
Figure 4: US Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Figure 5: US Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
Figure 6: US Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2024
Figure 7: Germany Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 - 2024
Figure 8: Germany Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Figure 9: Germany Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
Figure 10: Germany Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2024
Figure 11: France Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 - 2024
Figure 12: France Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Figure 13: France Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
Figure 14: France Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2024
Figure 15: Italy Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 - 2024
Figure 16: Italy Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Figure 17: Italy Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
Figure 18: Italy Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2024
Figure 19: Spain Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 - 2024
Figure 20: Spain Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Figure 21: Spain Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
Figure 22: Spain Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2024
Figure 23: UK Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 - 2024
Figure 24: UK Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Figure 25: UK Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
Figure 26: UK Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2024
Figure 27: Europe Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 - 2024
Figure 28: Europe Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Figure 29: Europe Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
Figure 30: Europe Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2024
Figure 31: Japan Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 - 2024
Figure 32: Japan Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Figure 33: Japan Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
Figure 34: Japan Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2024
Figure 35: Global Chronic Obstructive Pulmonary Disease Market Size ($mn), 2016 - 2024
Figure 36: Global Chronic Obstructive Pulmonary Disease Product Sales ($mn), 2016 - 2024
Figure 37: Global Chronic Obstructive Pulmonary Disease Market Share by Drugs (%), 2019
Figure 38: Global Chronic Obstructive Pulmonary Disease Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll